Catalyst Wire Dossier Catalyst Wire Dossier

Trudexa

adalimumab · Abbott Laboratories Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trudexa, covering 2008-02-14 to 2008-02-14. Get the full timeline:

Most recent: EMA Withdrawn: Trudexa (adalimumab) — Abbott Laboratories Ltd.

See pricing